1. Home
  2. Analysis
  3. Cefazolin-sodium
  4. Quetiapine-fumarate

Cefazolin sodium and Quetiapine fumarate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Cefazolin sodium and Quetiapine fumarate together.

The phase IV clinical study analyzes what interactions people who take Cefazolin sodium and Quetiapine fumarate have. It is created by eHealthMe based on reports of 4 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 27, 2023

4 people who take Cefazolin sodium and Quetiapine fumarate together, and have interactions are studied.

What is Cefazolin sodium?

Cefazolin sodium has active ingredients of cefazolin sodium. eHealthMe is studying from 2,899 Cefazolin sodium users for its effectiveness, alternative drugs and more.

What is Quetiapine fumarate?

Quetiapine fumarate has active ingredients of quetiapine fumarate. It is often used in insomnia. eHealthMe is studying from 22,797 Quetiapine fumarate users for its effectiveness, alternative drugs and more.

Number of Cefazolin sodium and Quetiapine fumarate reports submitted per year:

Cefazolin sodium and Quetiapine fumarate drug interactions.

Common Cefazolin Sodium and Quetiapine Fumarate drug interactions by gender *:

female:

  1. Hypoacusis
  2. Ileus
  3. Illusion
  4. Mobility decreased
  5. Rash maculo-papular
  6. Anosognosia
  7. Delusion
  8. Dermatitis infected
  9. Dyskinesia
  10. Dyspepsia

male:

  1. Cardiac disorder
  2. Dehydration
  3. Neoplasm progression

Common Cefazolin Sodium and Quetiapine Fumarate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Anosognosia
  2. Delusion
  3. Mobility decreased
  4. Rash maculo-papular
  5. Dermatitis infected
  6. Dyskinesia
  7. Dyspepsia
  8. Gallbladder necrosis
  9. Hallucination, auditory
  10. Hypoacusis

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin sodium and Quetiapine fumarate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Cefazolin sodium and Quetiapine fumarate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cefazolin sodium side effects:

Browse all side effects of Cefazolin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Quetiapine fumarate side effects:

Browse all side effects of Quetiapine fumarate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cefazolin sodium interactions:

Browse all interactions between Cefazolin sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Quetiapine fumarate interactions:

Browse all interactions between Quetiapine fumarate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium and quetiapine fumarate (the active ingredients of Cefazolin sodium and Quetiapine fumarate, respectively), and Cefazolin sodium and Quetiapine fumarate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cefazolin sodium and Quetiapine fumarate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.